PHARMAORIGIN ApS: Financial statements 2025
CVR: 29178291
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000. The solvency ratio was 100%.
- Gross Profit
- 0 kr.
- Profit/Loss
- 100,000 kr.
- Equity
- 1,477,000 kr.
- Total Assets
- 1,477,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 100 t. | 1.5 mio. | 0 |
| 2024 | - | 0 | 94 t. | 1.4 mio. | - |
| 2023 | - | 0 | 87 t. | 1.3 mio. | - |
| 2022 | - | - | 47 t. | 1.2 mio. | - |
| 2021 | - | - | 40 t. | 1.1 mio. | - |
Find more companies like PHARMAORIGIN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
PHARMAORIGIN ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 94,000.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.
